Dr. Chen Saijuan
陈赛娟
Hospital
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Experience
45+ years in hematology research and clinical practice (PhD from University of Paris VII, 1989)
Languages
French, English, Mandarin
Tenured Professor; Academician of the Chinese Academy of Engineering; Director of Shanghai Institute of Hematology; Director of State Key Laboratory of Medical Genomics
Co-developed the "Shanghai Protocol" for treating acute promyelocytic leukemia (APL) using all-trans retinoic acid combined with arsenic trioxide — making APL the first essentially curable acute myeloid leukemia, now adopted globally; Vice Chairman of the China Association for Science and Technology; research published in Nature, Blood, and other top journals; recipient of numerous national science awards
Dr. Chen is primarily a research leader and senior advisor. Patients with leukemia or complex blood cancers at Ruijin Hospital benefit from the treatment protocols and research infrastructure she built. Ruijin's Hematology department is home to the National Center for Hematology and is China's premier destination for leukemia treatment.
Research this doctor's background on trusted platforms.
Results are automated searches and may include other individuals with similar names.
Information is provided for reference only and may not reflect current conditions. Please verify directly with the hospital before making decisions.